HK1259613A1 - 新型5h-吡咯並[2，3-d]嘧啶-6(7h)-酮衍生物 - Google Patents
新型5h-吡咯並[2，3-d]嘧啶-6(7h)-酮衍生物Info
- Publication number
- HK1259613A1 HK1259613A1 HK19101800.7A HK19101800A HK1259613A1 HK 1259613 A1 HK1259613 A1 HK 1259613A1 HK 19101800 A HK19101800 A HK 19101800A HK 1259613 A1 HK1259613 A1 HK 1259613A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- pyrrolo
- pyrimidin
- derivative
- novel
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2016101599 | 2016-05-20 | ||
| PCT/JP2017/018825 WO2017200087A1 (ja) | 2016-05-20 | 2017-05-19 | 新規５Ｈ－ピロロ［２，３－ｄ］ピリミジン－６（７Ｈ）－オン誘導体 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1259613A1 true HK1259613A1 (zh) | 2019-12-06 |
Family
ID=60325930
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK19101800.7A HK1259613A1 (zh) | 2016-05-20 | 2019-01-31 | 新型5h-吡咯並[2，3-d]嘧啶-6(7h)-酮衍生物 |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US10538528B2 (zh) |
| EP (1) | EP3459953B1 (zh) |
| JP (1) | JP6576553B2 (zh) |
| KR (1) | KR102149734B1 (zh) |
| CN (1) | CN109153681B (zh) |
| AU (1) | AU2017265769B9 (zh) |
| BR (1) | BR112018073721B1 (zh) |
| CA (1) | CA3024831C (zh) |
| DK (1) | DK3459953T3 (zh) |
| ES (1) | ES2882018T3 (zh) |
| HK (1) | HK1259613A1 (zh) |
| HU (1) | HUE055846T2 (zh) |
| MA (1) | MA45048A (zh) |
| MX (1) | MX2018014022A (zh) |
| MY (1) | MY185962A (zh) |
| PH (1) | PH12018502411A1 (zh) |
| PL (1) | PL3459953T3 (zh) |
| PT (1) | PT3459953T (zh) |
| RU (1) | RU2713181C1 (zh) |
| SG (1) | SG11201810360YA (zh) |
| TW (2) | TWI732187B (zh) |
| WO (1) | WO2017200087A1 (zh) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20240089357A (ko) * | 2021-10-13 | 2024-06-20 | 다이호야쿠힌고교 가부시키가이샤 | 조절장애 mapk 및/또는 pi3k 경로를 갖는 암을 갖는 대상체를 위한 치료 방법 |
| CN118525022A (zh) * | 2022-01-27 | 2024-08-20 | 西藏海思科制药有限公司 | 一种氮杂并环衍生物及其在医药上的应用 |
| WO2024009977A1 (ja) * | 2022-07-05 | 2024-01-11 | 大鵬薬品工業株式会社 | ５Ｈ－ピロロ［２，３－ｄ］ピリミジン－６（７Ｈ）－オン及びその塩体の結晶 |
| CN115850244B (zh) * | 2023-02-24 | 2023-05-16 | 成都大学 | 一种托吡司他的制备方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2563699C (en) | 2004-04-23 | 2014-03-25 | Exelixis, Inc. | Kinase modulators and method of use |
| GB0608184D0 (en) * | 2006-04-25 | 2006-06-07 | Astex Therapeutics Ltd | Pharmaceutical compounds |
| AR064416A1 (es) * | 2006-12-21 | 2009-04-01 | Cancer Rec Tech Ltd | Derivados de purina, piridina y pirimidina condensadas con heterociclos, moduladores de pka y/o pkb, composiciones farmaceuticas que los contienen, y usos para el tratamiento de enfermedades hiperproliferativas. |
| JP5608647B2 (ja) * | 2008-08-08 | 2014-10-15 | ネステク ソシエテ アノニム | 持ち運びハンドルおよび設定変更可能な外観ならびに副次的機能を伴う飲料装置 |
| AR074072A1 (es) * | 2008-11-11 | 2010-12-22 | Lilly Co Eli | Compuesto de imidazol -piperidin -pirrol-pirimidin-6-ona, composicion farmaceutica que lo comprende y su uso para preparar un medicamento util para tratar el glioblastoma multiforme |
| EP2491032B1 (en) * | 2009-10-23 | 2014-04-16 | Eli Lilly and Company | Akt inhibitors |
| KR20150124957A (ko) * | 2013-03-11 | 2015-11-06 | 메르크 파텐트 게엠베하 | 키나아제 활성의 조절인자로서 (6-[4-1h-이미다졸-2-일)피페리딘-1-일]피리미딘-4-아민 유도체 |
| JP6398659B2 (ja) | 2014-11-28 | 2018-10-03 | アイシン・エィ・ダブリュ株式会社 | 歯形部品の製造方法および歯形部品製造装置 |
-
2017
- 2017-05-19 TW TW108107835A patent/TWI732187B/zh active
- 2017-05-19 RU RU2018144542A patent/RU2713181C1/ru active
- 2017-05-19 KR KR1020187030344A patent/KR102149734B1/ko active IP Right Grant
- 2017-05-19 DK DK17799511.5T patent/DK3459953T3/da active
- 2017-05-19 TW TW106116606A patent/TWI679202B/zh active
- 2017-05-19 MX MX2018014022A patent/MX2018014022A/es active IP Right Grant
- 2017-05-19 MY MYPI2018704229A patent/MY185962A/en unknown
- 2017-05-19 MA MA045048A patent/MA45048A/fr unknown
- 2017-05-19 PT PT177995115T patent/PT3459953T/pt unknown
- 2017-05-19 CN CN201780030144.3A patent/CN109153681B/zh active Active
- 2017-05-19 EP EP17799511.5A patent/EP3459953B1/en active Active
- 2017-05-19 WO PCT/JP2017/018825 patent/WO2017200087A1/ja active Application Filing
- 2017-05-19 BR BR112018073721-6A patent/BR112018073721B1/pt active IP Right Grant
- 2017-05-19 AU AU2017265769A patent/AU2017265769B9/en active Active
- 2017-05-19 JP JP2018518384A patent/JP6576553B2/ja active Active
- 2017-05-19 HU HUE17799511A patent/HUE055846T2/hu unknown
- 2017-05-19 ES ES17799511T patent/ES2882018T3/es active Active
- 2017-05-19 SG SG11201810360YA patent/SG11201810360YA/en unknown
- 2017-05-19 US US16/302,829 patent/US10538528B2/en active Active
- 2017-05-19 CA CA3024831A patent/CA3024831C/en active Active
- 2017-05-19 PL PL17799511T patent/PL3459953T3/pl unknown
-
2018
- 2018-11-15 PH PH12018502411A patent/PH12018502411A1/en unknown
-
2019
- 2019-01-31 HK HK19101800.7A patent/HK1259613A1/zh unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201905456B (en) | Pyrrolo[1,2-b]pyridazine derivatives | |
| HK1245764A1 (zh) | 3-取代的5-氨基-6h-噻唑並[4，5-d]嘧啶-2，7-二酮化合物 | |
| HK1258157A1 (zh) | 作為jak抑制劑的吡唑並[1，5-a]吡嗪-4-基衍生物 | |
| HK1246792A1 (zh) | 6，7-二氫吡唑並[1，5-a]吡嗪-4(5h)-酮化合物 | |
| IL250823A0 (en) | A new derivative of 6,5-dihydro-h4-benzo[b]thiano-[3,2-d]azepine | |
| HK1256751A1 (zh) | [1，2，4]三唑並[1，5-a]嘧啶-7-基化合物 | |
| EP3452481A4 (en) | IMIDAZO [1,2-B] SUBSTITUTED PYRIDAZINES, IMIDAZO [1,5-B] SUBSTITUTED PYRIDAZINES, RELATED COMPOUNDS AND THEIR USE IN THE TREATMENT OF MEDICAL CONDITIONS | |
| IL243092B (en) | New triazolo[d–4,5]pyrimidine histories | |
| HK1259613A1 (zh) | 新型5h-吡咯並[2，3-d]嘧啶-6(7h)-酮衍生物 | |
| ZA201605666B (en) | Pyrazolo[1,5-a]pyrimidines as antiviral compounds | |
| PL3129374T3 (pl) | (5,6-Dihydro)pirymido[4,5-e]indolizyny | |
| IL262673A (en) | A pyrazolo[5,1-a]pyrimidine compound | |
| ZA202100259B (en) | Pyrrolo[1,2-b]pyridazine derivatives | |
| GB201522532D0 (en) | Novel pyrrolo[3,2-c]pyridine-6-amino derivatives | |
| HK1257427A1 (zh) | 用於製備2-吡唑並[1，5-a]吡嗪-2-基吡啶並[1，2-a]嘧啶-4-酮的方法 |